nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2B—cardial valve—systemic scleroderma	0.0833	0.236	CbGeAlD
Methysergide—HTR7—myenteric nerve plexus—systemic scleroderma	0.0408	0.115	CbGeAlD
Methysergide—HTR7—pulmonary artery—systemic scleroderma	0.0289	0.0817	CbGeAlD
Methysergide—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0254	0.072	CbGeAlD
Methysergide—HTR2A—pulmonary artery—systemic scleroderma	0.018	0.051	CbGeAlD
Methysergide—HTR1B—artery—systemic scleroderma	0.0139	0.0393	CbGeAlD
Methysergide—HTR1D—artery—systemic scleroderma	0.0134	0.038	CbGeAlD
Methysergide—HTR1B—blood vessel—systemic scleroderma	0.0108	0.0306	CbGeAlD
Methysergide—HTR7—artery—systemic scleroderma	0.0107	0.0303	CbGeAlD
Methysergide—HTR1D—blood vessel—systemic scleroderma	0.0105	0.0296	CbGeAlD
Methysergide—HTR7—endothelium—systemic scleroderma	0.00904	0.0256	CbGeAlD
Methysergide—HTR7—blood vessel—systemic scleroderma	0.00834	0.0236	CbGeAlD
Methysergide—HTR2A—artery—systemic scleroderma	0.00668	0.0189	CbGeAlD
Methysergide—HTR2A—endothelium—systemic scleroderma	0.00564	0.016	CbGeAlD
Methysergide—HTR1D—connective tissue—systemic scleroderma	0.00537	0.0152	CbGeAlD
Methysergide—HTR2A—blood vessel—systemic scleroderma	0.0052	0.0147	CbGeAlD
Methysergide—SIGMAR1—smooth muscle tissue—systemic scleroderma	0.00458	0.013	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—systemic scleroderma	0.00457	0.0129	CbGeAlD
Methysergide—HTR2B—skin of body—systemic scleroderma	0.00451	0.0128	CbGeAlD
Methysergide—HTR7—connective tissue—systemic scleroderma	0.00428	0.0121	CbGeAlD
Methysergide—HTR7—smooth muscle tissue—systemic scleroderma	0.00391	0.0111	CbGeAlD
Methysergide—HTR2B—digestive system—systemic scleroderma	0.00361	0.0102	CbGeAlD
Methysergide—SIGMAR1—tendon—systemic scleroderma	0.00344	0.00973	CbGeAlD
Methysergide—HTR2B—tendon—systemic scleroderma	0.00343	0.00971	CbGeAlD
Methysergide—HTR7—digestive system—systemic scleroderma	0.00309	0.00874	CbGeAlD
Methysergide—SIGMAR1—lung—systemic scleroderma	0.00302	0.00854	CbGeAlD
Methysergide—HTR2B—lung—systemic scleroderma	0.00301	0.00852	CbGeAlD
Methysergide—HTR7—tendon—systemic scleroderma	0.00294	0.00832	CbGeAlD
Methysergide—HTR2A—connective tissue—systemic scleroderma	0.00267	0.00754	CbGeAlD
Methysergide—HTR7—lung—systemic scleroderma	0.00258	0.0073	CbGeAlD
Methysergide—HTR2A—smooth muscle tissue—systemic scleroderma	0.00244	0.0069	CbGeAlD
Methysergide—HTR2A—digestive system—systemic scleroderma	0.00193	0.00545	CbGeAlD
Methysergide—HTR2A—tendon—systemic scleroderma	0.00183	0.00519	CbGeAlD
Methysergide—Alopecia—Mycophenolic acid—systemic scleroderma	0.00183	0.00283	CcSEcCtD
Methysergide—Back pain—Leflunomide—systemic scleroderma	0.00183	0.00283	CcSEcCtD
Methysergide—Tachycardia—Captopril—systemic scleroderma	0.00183	0.00282	CcSEcCtD
Methysergide—Pain—Mometasone—systemic scleroderma	0.00182	0.00282	CcSEcCtD
Methysergide—Malaise—Azathioprine—systemic scleroderma	0.0018	0.00279	CcSEcCtD
Methysergide—Asthenia—Pentoxifylline—systemic scleroderma	0.00177	0.00274	CcSEcCtD
Methysergide—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00175	0.00271	CcSEcCtD
Methysergide—Back pain—Mycophenolic acid—systemic scleroderma	0.00174	0.0027	CcSEcCtD
Methysergide—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00174	0.00269	CcSEcCtD
Methysergide—Flushing—Lisinopril—systemic scleroderma	0.00173	0.00268	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.0017	0.00264	CcSEcCtD
Methysergide—Malaise—Leflunomide—systemic scleroderma	0.0017	0.00263	CcSEcCtD
Methysergide—Arthralgia—Azathioprine—systemic scleroderma	0.0017	0.00263	CcSEcCtD
Methysergide—Myalgia—Azathioprine—systemic scleroderma	0.0017	0.00263	CcSEcCtD
Methysergide—Insomnia—Captopril—systemic scleroderma	0.00169	0.00262	CcSEcCtD
Methysergide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00169	0.00261	CcSEcCtD
Methysergide—Abdominal pain—Mometasone—systemic scleroderma	0.00168	0.0026	CcSEcCtD
Methysergide—Body temperature increased—Mometasone—systemic scleroderma	0.00168	0.0026	CcSEcCtD
Methysergide—Discomfort—Azathioprine—systemic scleroderma	0.00168	0.0026	CcSEcCtD
Methysergide—Paraesthesia—Captopril—systemic scleroderma	0.00168	0.0026	CcSEcCtD
Methysergide—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00167	0.00259	CcSEcCtD
Methysergide—Dyspnoea—Captopril—systemic scleroderma	0.00167	0.00258	CcSEcCtD
Methysergide—Urine output increased—Methotrexate—systemic scleroderma	0.00167	0.00258	CcSEcCtD
Methysergide—Somnolence—Captopril—systemic scleroderma	0.00166	0.00257	CcSEcCtD
Methysergide—Alopecia—Lisinopril—systemic scleroderma	0.00165	0.00255	CcSEcCtD
Methysergide—Dyspepsia—Captopril—systemic scleroderma	0.00165	0.00255	CcSEcCtD
Methysergide—Dizziness—Pentoxifylline—systemic scleroderma	0.00163	0.00252	CcSEcCtD
Methysergide—Malaise—Mycophenolic acid—systemic scleroderma	0.00162	0.00251	CcSEcCtD
Methysergide—Fatigue—Captopril—systemic scleroderma	0.00161	0.00249	CcSEcCtD
Methysergide—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00249	CcSEcCtD
Methysergide—HTR2A—lung—systemic scleroderma	0.00161	0.00455	CbGeAlD
Methysergide—Arthralgia—Leflunomide—systemic scleroderma	0.00161	0.00249	CcSEcCtD
Methysergide—Chest pain—Leflunomide—systemic scleroderma	0.00161	0.00249	CcSEcCtD
Methysergide—Myalgia—Leflunomide—systemic scleroderma	0.00161	0.00249	CcSEcCtD
Methysergide—Constipation—Captopril—systemic scleroderma	0.0016	0.00247	CcSEcCtD
Methysergide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.0016	0.00247	CcSEcCtD
Methysergide—Discomfort—Leflunomide—systemic scleroderma	0.00159	0.00246	CcSEcCtD
Methysergide—Back pain—Lisinopril—systemic scleroderma	0.00157	0.00243	CcSEcCtD
Methysergide—Vomiting—Pentoxifylline—systemic scleroderma	0.00157	0.00243	CcSEcCtD
Methysergide—Convulsion—Mycophenolic acid—systemic scleroderma	0.00156	0.00241	CcSEcCtD
Methysergide—Rash—Pentoxifylline—systemic scleroderma	0.00156	0.00241	CcSEcCtD
Methysergide—Dermatitis—Pentoxifylline—systemic scleroderma	0.00155	0.0024	CcSEcCtD
Methysergide—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00155	0.00239	CcSEcCtD
Methysergide—Feeling abnormal—Captopril—systemic scleroderma	0.00154	0.00238	CcSEcCtD
Methysergide—Myalgia—Mycophenolic acid—systemic scleroderma	0.00153	0.00237	CcSEcCtD
Methysergide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00153	0.00237	CcSEcCtD
Methysergide—Chest pain—Mycophenolic acid—systemic scleroderma	0.00153	0.00237	CcSEcCtD
Methysergide—Gastrointestinal pain—Captopril—systemic scleroderma	0.00153	0.00237	CcSEcCtD
Methysergide—Asthenia—Mometasone—systemic scleroderma	0.00153	0.00236	CcSEcCtD
Methysergide—Polyuria—Methotrexate—systemic scleroderma	0.00152	0.00236	CcSEcCtD
Methysergide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00152	0.00234	CcSEcCtD
Methysergide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00151	0.00233	CcSEcCtD
Methysergide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00151	0.00233	CcSEcCtD
Methysergide—Tachycardia—Leflunomide—systemic scleroderma	0.0015	0.00233	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00149	0.0023	CcSEcCtD
Methysergide—Abdominal pain—Captopril—systemic scleroderma	0.00148	0.00229	CcSEcCtD
Methysergide—Body temperature increased—Captopril—systemic scleroderma	0.00148	0.00229	CcSEcCtD
Methysergide—Oedema—Mycophenolic acid—systemic scleroderma	0.00147	0.00227	CcSEcCtD
Methysergide—Nausea—Pentoxifylline—systemic scleroderma	0.00147	0.00227	CcSEcCtD
Methysergide—Malaise—Lisinopril—systemic scleroderma	0.00146	0.00226	CcSEcCtD
Methysergide—Diarrhoea—Mometasone—systemic scleroderma	0.00146	0.00225	CcSEcCtD
Methysergide—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00223	CcSEcCtD
Methysergide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00144	0.00223	CcSEcCtD
Methysergide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00144	0.00222	CcSEcCtD
Methysergide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00141	0.00218	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.0014	0.00217	CcSEcCtD
Methysergide—Insomnia—Leflunomide—systemic scleroderma	0.00139	0.00216	CcSEcCtD
Methysergide—Paraesthesia—Leflunomide—systemic scleroderma	0.00138	0.00214	CcSEcCtD
Methysergide—Arthralgia—Lisinopril—systemic scleroderma	0.00138	0.00214	CcSEcCtD
Methysergide—Chest pain—Lisinopril—systemic scleroderma	0.00138	0.00214	CcSEcCtD
Methysergide—Myalgia—Lisinopril—systemic scleroderma	0.00138	0.00214	CcSEcCtD
Methysergide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00213	CcSEcCtD
Methysergide—Dyspnoea—Leflunomide—systemic scleroderma	0.00137	0.00213	CcSEcCtD
Methysergide—Discomfort—Lisinopril—systemic scleroderma	0.00137	0.00211	CcSEcCtD
Methysergide—Dyspepsia—Leflunomide—systemic scleroderma	0.00136	0.0021	CcSEcCtD
Methysergide—Vomiting—Mometasone—systemic scleroderma	0.00135	0.00209	CcSEcCtD
Methysergide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00135	0.00208	CcSEcCtD
Methysergide—Rash—Mometasone—systemic scleroderma	0.00134	0.00208	CcSEcCtD
Methysergide—Asthenia—Captopril—systemic scleroderma	0.00134	0.00208	CcSEcCtD
Methysergide—Dermatitis—Mometasone—systemic scleroderma	0.00134	0.00207	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00134	0.00207	CcSEcCtD
Methysergide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00133	0.00206	CcSEcCtD
Methysergide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00133	0.00206	CcSEcCtD
Methysergide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00133	0.00206	CcSEcCtD
Methysergide—Fatigue—Leflunomide—systemic scleroderma	0.00133	0.00206	CcSEcCtD
Methysergide—Oedema—Lisinopril—systemic scleroderma	0.00132	0.00205	CcSEcCtD
Methysergide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00132	0.00204	CcSEcCtD
Methysergide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00204	CcSEcCtD
Methysergide—Pain—Leflunomide—systemic scleroderma	0.00132	0.00204	CcSEcCtD
Methysergide—Constipation—Leflunomide—systemic scleroderma	0.00132	0.00204	CcSEcCtD
Methysergide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00131	0.00203	CcSEcCtD
Methysergide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00131	0.00202	CcSEcCtD
Methysergide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0013	0.00201	CcSEcCtD
Methysergide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00129	0.002	CcSEcCtD
Methysergide—Neutropenia—Prednisone—systemic scleroderma	0.00129	0.002	CcSEcCtD
Methysergide—Tachycardia—Lisinopril—systemic scleroderma	0.00129	0.002	CcSEcCtD
Methysergide—Abdominal pain—Azathioprine—systemic scleroderma	0.00129	0.002	CcSEcCtD
Methysergide—Body temperature increased—Azathioprine—systemic scleroderma	0.00129	0.002	CcSEcCtD
Methysergide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00198	CcSEcCtD
Methysergide—Diarrhoea—Captopril—systemic scleroderma	0.00128	0.00198	CcSEcCtD
Methysergide—Feeling abnormal—Leflunomide—systemic scleroderma	0.00127	0.00196	CcSEcCtD
Methysergide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00127	0.00196	CcSEcCtD
Methysergide—Fatigue—Mycophenolic acid—systemic scleroderma	0.00127	0.00196	CcSEcCtD
Methysergide—Nausea—Mometasone—systemic scleroderma	0.00126	0.00196	CcSEcCtD
Methysergide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00126	0.00195	CcSEcCtD
Methysergide—Weight increased—Prednisone—systemic scleroderma	0.00126	0.00195	CcSEcCtD
Methysergide—Ataxia—Methotrexate—systemic scleroderma	0.00126	0.00195	CcSEcCtD
Methysergide—Constipation—Mycophenolic acid—systemic scleroderma	0.00126	0.00194	CcSEcCtD
Methysergide—Pain—Mycophenolic acid—systemic scleroderma	0.00126	0.00194	CcSEcCtD
Methysergide—Weight decreased—Prednisone—systemic scleroderma	0.00125	0.00194	CcSEcCtD
Methysergide—Dizziness—Captopril—systemic scleroderma	0.00124	0.00191	CcSEcCtD
Methysergide—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00191	CcSEcCtD
Methysergide—Abdominal pain—Leflunomide—systemic scleroderma	0.00122	0.00188	CcSEcCtD
Methysergide—Body temperature increased—Leflunomide—systemic scleroderma	0.00122	0.00188	CcSEcCtD
Methysergide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00121	0.00187	CcSEcCtD
Methysergide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00187	CcSEcCtD
Methysergide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00187	CcSEcCtD
Methysergide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00187	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00121	0.00187	CcSEcCtD
Methysergide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0012	0.00186	CcSEcCtD
Methysergide—Insomnia—Lisinopril—systemic scleroderma	0.0012	0.00185	CcSEcCtD
Methysergide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00185	CcSEcCtD
Methysergide—Paraesthesia—Lisinopril—systemic scleroderma	0.00119	0.00184	CcSEcCtD
Methysergide—Vomiting—Captopril—systemic scleroderma	0.00119	0.00184	CcSEcCtD
Methysergide—Dyspnoea—Lisinopril—systemic scleroderma	0.00118	0.00183	CcSEcCtD
Methysergide—Rash—Captopril—systemic scleroderma	0.00118	0.00182	CcSEcCtD
Methysergide—Dermatitis—Captopril—systemic scleroderma	0.00118	0.00182	CcSEcCtD
Methysergide—Somnolence—Lisinopril—systemic scleroderma	0.00118	0.00182	CcSEcCtD
Methysergide—Dyspepsia—Lisinopril—systemic scleroderma	0.00117	0.0018	CcSEcCtD
Methysergide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00116	0.0018	CcSEcCtD
Methysergide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00116	0.0018	CcSEcCtD
Methysergide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00179	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—systemic scleroderma	0.00114	0.00177	CcSEcCtD
Methysergide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00114	0.00177	CcSEcCtD
Methysergide—Fatigue—Lisinopril—systemic scleroderma	0.00114	0.00177	CcSEcCtD
Methysergide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00176	CcSEcCtD
Methysergide—Pain—Lisinopril—systemic scleroderma	0.00113	0.00175	CcSEcCtD
Methysergide—Constipation—Lisinopril—systemic scleroderma	0.00113	0.00175	CcSEcCtD
Methysergide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00175	CcSEcCtD
Methysergide—Diarrhoea—Azathioprine—systemic scleroderma	0.00112	0.00173	CcSEcCtD
Methysergide—Nausea—Captopril—systemic scleroderma	0.00111	0.00172	CcSEcCtD
Methysergide—Asthenia—Leflunomide—systemic scleroderma	0.00111	0.00171	CcSEcCtD
Methysergide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00109	0.00169	CcSEcCtD
Methysergide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00108	0.00168	CcSEcCtD
Methysergide—Dysuria—Methotrexate—systemic scleroderma	0.00108	0.00167	CcSEcCtD
Methysergide—Neutropenia—Methotrexate—systemic scleroderma	0.00108	0.00167	CcSEcCtD
Methysergide—Dizziness—Azathioprine—systemic scleroderma	0.00108	0.00167	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00164	CcSEcCtD
Methysergide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00106	0.00163	CcSEcCtD
Methysergide—Diarrhoea—Leflunomide—systemic scleroderma	0.00105	0.00163	CcSEcCtD
Methysergide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00162	CcSEcCtD
Methysergide—Body temperature increased—Lisinopril—systemic scleroderma	0.00105	0.00162	CcSEcCtD
Methysergide—Abdominal pain—Lisinopril—systemic scleroderma	0.00105	0.00162	CcSEcCtD
Methysergide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00161	CcSEcCtD
Methysergide—Vomiting—Azathioprine—systemic scleroderma	0.00104	0.00161	CcSEcCtD
Methysergide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00103	0.0016	CcSEcCtD
Methysergide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00103	0.0016	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Methysergide—Rash—Azathioprine—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Methysergide—Dermatitis—Azathioprine—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Methysergide—Flushing—Prednisone—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Methysergide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00158	CcSEcCtD
Methysergide—Dizziness—Leflunomide—systemic scleroderma	0.00102	0.00158	CcSEcCtD
Methysergide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00101	0.00156	CcSEcCtD
Methysergide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.001	0.00155	CcSEcCtD
Methysergide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000992	0.00153	CcSEcCtD
Methysergide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000992	0.00153	CcSEcCtD
Methysergide—Vomiting—Leflunomide—systemic scleroderma	0.00098	0.00152	CcSEcCtD
Methysergide—Alopecia—Prednisone—systemic scleroderma	0.000978	0.00151	CcSEcCtD
Methysergide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000972	0.0015	CcSEcCtD
Methysergide—Rash—Leflunomide—systemic scleroderma	0.000972	0.0015	CcSEcCtD
Methysergide—Dermatitis—Leflunomide—systemic scleroderma	0.000971	0.0015	CcSEcCtD
Methysergide—Nausea—Azathioprine—systemic scleroderma	0.00097	0.0015	CcSEcCtD
Methysergide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000956	0.00148	CcSEcCtD
Methysergide—Asthenia—Lisinopril—systemic scleroderma	0.00095	0.00147	CcSEcCtD
Methysergide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000949	0.00147	CcSEcCtD
Methysergide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000935	0.00145	CcSEcCtD
Methysergide—Rash—Mycophenolic acid—systemic scleroderma	0.000927	0.00143	CcSEcCtD
Methysergide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000926	0.00143	CcSEcCtD
Methysergide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00142	CcSEcCtD
Methysergide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00142	CcSEcCtD
Methysergide—Nausea—Leflunomide—systemic scleroderma	0.000916	0.00142	CcSEcCtD
Methysergide—Diarrhoea—Lisinopril—systemic scleroderma	0.000906	0.0014	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000894	0.00138	CcSEcCtD
Methysergide—Dizziness—Lisinopril—systemic scleroderma	0.000876	0.00135	CcSEcCtD
Methysergide—Nausea—Mycophenolic acid—systemic scleroderma	0.000873	0.00135	CcSEcCtD
Methysergide—Malaise—Prednisone—systemic scleroderma	0.000869	0.00134	CcSEcCtD
Methysergide—Vomiting—Lisinopril—systemic scleroderma	0.000842	0.0013	CcSEcCtD
Methysergide—Rash—Lisinopril—systemic scleroderma	0.000835	0.00129	CcSEcCtD
Methysergide—Convulsion—Prednisone—systemic scleroderma	0.000835	0.00129	CcSEcCtD
Methysergide—Dermatitis—Lisinopril—systemic scleroderma	0.000834	0.00129	CcSEcCtD
Methysergide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000833	0.00129	CcSEcCtD
Methysergide—Arthralgia—Prednisone—systemic scleroderma	0.000821	0.00127	CcSEcCtD
Methysergide—Myalgia—Prednisone—systemic scleroderma	0.000821	0.00127	CcSEcCtD
Methysergide—Alopecia—Methotrexate—systemic scleroderma	0.000818	0.00126	CcSEcCtD
Methysergide—Discomfort—Prednisone—systemic scleroderma	0.000811	0.00125	CcSEcCtD
Methysergide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000794	0.00123	CcSEcCtD
Methysergide—Nausea—Lisinopril—systemic scleroderma	0.000787	0.00122	CcSEcCtD
Methysergide—Oedema—Prednisone—systemic scleroderma	0.000787	0.00122	CcSEcCtD
Methysergide—Back pain—Methotrexate—systemic scleroderma	0.000779	0.00121	CcSEcCtD
Methysergide—Tachycardia—Prednisone—systemic scleroderma	0.000768	0.00119	CcSEcCtD
Methysergide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000767	0.00119	CcSEcCtD
Methysergide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000747	0.00116	CcSEcCtD
Methysergide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000738	0.00114	CcSEcCtD
Methysergide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000732	0.00113	CcSEcCtD
Methysergide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000731	0.00113	CcSEcCtD
Methysergide—Malaise—Methotrexate—systemic scleroderma	0.000726	0.00112	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000717	0.00111	CcSEcCtD
Methysergide—Insomnia—Prednisone—systemic scleroderma	0.000712	0.0011	CcSEcCtD
Methysergide—Paraesthesia—Prednisone—systemic scleroderma	0.000706	0.00109	CcSEcCtD
Methysergide—Convulsion—Methotrexate—systemic scleroderma	0.000698	0.00108	CcSEcCtD
Methysergide—Dyspepsia—Prednisone—systemic scleroderma	0.000692	0.00107	CcSEcCtD
Methysergide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000689	0.00107	CcSEcCtD
Methysergide—Myalgia—Methotrexate—systemic scleroderma	0.000686	0.00106	CcSEcCtD
Methysergide—Chest pain—Methotrexate—systemic scleroderma	0.000686	0.00106	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—systemic scleroderma	0.000686	0.00106	CcSEcCtD
Methysergide—Fatigue—Prednisone—systemic scleroderma	0.000678	0.00105	CcSEcCtD
Methysergide—Discomfort—Methotrexate—systemic scleroderma	0.000678	0.00105	CcSEcCtD
Methysergide—Constipation—Prednisone—systemic scleroderma	0.000673	0.00104	CcSEcCtD
Methysergide—Feeling abnormal—Prednisone—systemic scleroderma	0.000648	0.001	CcSEcCtD
Methysergide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000644	0.000996	CcSEcCtD
Methysergide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000643	0.000995	CcSEcCtD
Methysergide—Body temperature increased—Prednisone—systemic scleroderma	0.000622	0.000962	CcSEcCtD
Methysergide—Abdominal pain—Prednisone—systemic scleroderma	0.000622	0.000962	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000599	0.000926	CcSEcCtD
Methysergide—Insomnia—Methotrexate—systemic scleroderma	0.000595	0.00092	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—systemic scleroderma	0.00059	0.000913	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—systemic scleroderma	0.000586	0.000906	CcSEcCtD
Methysergide—Somnolence—Methotrexate—systemic scleroderma	0.000584	0.000904	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—systemic scleroderma	0.000579	0.000895	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000568	0.000878	CcSEcCtD
Methysergide—Fatigue—Methotrexate—systemic scleroderma	0.000567	0.000877	CcSEcCtD
Methysergide—Asthenia—Prednisone—systemic scleroderma	0.000564	0.000873	CcSEcCtD
Methysergide—Pain—Methotrexate—systemic scleroderma	0.000562	0.000869	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000542	0.000838	CcSEcCtD
Methysergide—Diarrhoea—Prednisone—systemic scleroderma	0.000538	0.000832	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000538	0.000831	CcSEcCtD
Methysergide—Dizziness—Prednisone—systemic scleroderma	0.00052	0.000805	CcSEcCtD
Methysergide—Abdominal pain—Methotrexate—systemic scleroderma	0.00052	0.000804	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—systemic scleroderma	0.00052	0.000804	CcSEcCtD
Methysergide—Vomiting—Prednisone—systemic scleroderma	0.0005	0.000774	CcSEcCtD
Methysergide—Rash—Prednisone—systemic scleroderma	0.000496	0.000767	CcSEcCtD
Methysergide—Dermatitis—Prednisone—systemic scleroderma	0.000496	0.000766	CcSEcCtD
Methysergide—Asthenia—Methotrexate—systemic scleroderma	0.000472	0.00073	CcSEcCtD
Methysergide—Nausea—Prednisone—systemic scleroderma	0.000467	0.000723	CcSEcCtD
Methysergide—Diarrhoea—Methotrexate—systemic scleroderma	0.00045	0.000696	CcSEcCtD
Methysergide—Dizziness—Methotrexate—systemic scleroderma	0.000435	0.000672	CcSEcCtD
Methysergide—Vomiting—Methotrexate—systemic scleroderma	0.000418	0.000646	CcSEcCtD
Methysergide—Rash—Methotrexate—systemic scleroderma	0.000415	0.000641	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—systemic scleroderma	0.000414	0.00064	CcSEcCtD
Methysergide—Nausea—Methotrexate—systemic scleroderma	0.000391	0.000604	CcSEcCtD
